FOR US RESIDENTS ONLY
Send Email  SEND TO A COLLEAGUE   |   Print this page PRINT PAGE   |  A A A
Treatment Support Program Health Care Professionals and Patients
Key
Helping Healthcare Professionals
Optimize Outcomes in Ph+ CML Patients

CML Alliance Treatment Support Program

Novartis, the global leader in Ph+ CML therapy, has been working with healthcare professionals and patients worldwide for more than 5 years to improve the treatment of Ph+ CML.

Novartis introduces CML Alliance™, a unique support program designed to help healthcare professionals optimize outcomes in Ph+ CML patients.

 

Testing services offered through CML Alliance™ partners

Avantix-Free Blood Testing Enrollment


Information for CML Patients
Molecular MD BCR-ABL testing Genzyme BCR-ABL Testing